Cart
sales@molnova.com
SBC-115337
CAS No. 423148-46-3
SBC-115337( —— )
Catalog No. M24388 CAS No. 423148-46-3
SBC-115337 is a PCSK9 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 141 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 372 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 681 | In Stock |
|
| 200MG | 917 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSBC-115337
-
NoteResearch use only, not for human use.
-
Brief DescriptionSBC-115337 is a PCSK9 inhibitor.
-
DescriptionSBC-115337 is a PCSK9 inhibitor.
-
In VitroThe potent compound (SBC-115,337) shows an IC50 of 0.6 μM measured in an in vitro ELISA assay to monitor the effect of PCSK9 binding to the recombinant LDLR. SBC-115,337 at 1.2 μM induces more than tenfold upregulation of LDLR in HepG2 cells with respect to the control, increases uptake of fluorescently labeled DiI-LDL and loweres LDL-c levels in mice fed a high-fat diet.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPSCK9
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number423148-46-3
-
Formula Weight473.48
-
Molecular FormulaC29H19N3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6mg/mL?(12.67mM;ultrasonic and warming and heat to 60℃)
-
SMILESO=C(C1=CC2=CC=CC=C2O1)NC3=CC=C(C(NC4=CC=C(C5=NC6=CC=CC=C6O5)C=C4)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lavecchia A , Cerchia C . Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy[J]. Future medicinal chemistry, 2019, 11(5):423-441.
molnova catalog
related products
-
hPL-IN-2
hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases.
-
(Lys8,Lys9)-Neuroten...
[Lys8, Lys9]-Neurotensin (8-13) (JMV438), a Neurotensin analog, exerts its analgesic effects through activation of the G protein-coupled receptors NTS1 and NTS2, with Ki values of 0.33 nM and 0.95 nM for hNTS1 and hNTS2 receptors, respectively.
-
Coumarin-3-carboxyli...
The combination of Valproic acid with coumarin-3-carboxylic acid suppresses the proliferation and migration of lung cancer cells via EGFR/VEGFR2/c-Met-Akt-NF-κB signaling pathways.
